Fig. 2From: Coding joint: kappa-deleting recombination excision circle ratio and B cell activating factor level: predicting juvenile dermatomyositis rituximab response, a proof-of-concept studyJDM disease course and CJ:KREC ratio. JDM patient response to Rituximab measured by Disease Activity Score (DAS) and its relation to CJ:KREC ratioBack to article page